March On Nowhere: Who’s Next?


In the US, Fentanyl caused 20,100 deaths in 2016, a rise of 540% over the past 3 years.

It is about 75 times stronger than morphine for a given amount. Some fentanyl analogues may be as much as 10,000 times stronger than morphine.















This is a product manufactured by a vile “pharmaceutical,” oh sorry…”Biotech” company called Insys Therapeutics, based in Arizona.

In 2016 Insys Therapeutics donated $500,000 to an “activist” group called Arizonans For Responsible Drug Policy, which opposes legalization of marijuana and peddles stories to bought media that we must “raise awareness of the harms of marijuana,” and “protect our children.”

This is literally mass death for mass profit, with full media complicity and societal apathy/silence.

No Psy-Op.

No “brave” kids who get to speak out on camera about what it felt like to see their friends die.

Why no outrage over our failure to ban Fentanyl? You’re barely allowed to say it killed Prince and Tom Petty, but it did. Among countless others.
Here’s a nice little story about the company’s stock value, as it seeks to launch something probably even deadlier. Why stop at 75-10,000 times more potent than morphine?

Behold this insane passage of stock market reportage, from Jan 4, 2018:

“Fortunately, the low point was when pessimism over allegations of off-label marketing for its fentanyl opioid spray, Subsys, were at their maximum. Investors seem to be hoping a $150 million reserve Insys has set aside to settle lawsuits will be enough to squelch the Subsys problem.

Insys’ long-term value will be tied to Syndros, which hit the market last year and its buprenorphine sublingual spray for moderate-to-severe acute pain, which is currently under review by the Food and Drug Administration. If Insys can make the Subsys lawsuits go away and produce decent sales from the two new drugs, its current $800 million market cap is certainly a reasonable valuation.”

–Brian Orelli

#No Lives Matter To Pharma

Why Insys Therapeutics Inc. Crashed Today
What goes up must come down.

Article By Celia Farber

2 thoughts on “March On Nowhere: Who’s Next?”

  1. “Investors seem to be hoping….” Sadly this is what it all comes down to, how much money can be made in these situations, to hell with the consequences.

Leave a Reply

Your email address will not be published.